Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Is IVUS Guided PCI a Common Technique?

We all know the benefits of ultravascular ultrasound (IVUS) in the development of percutaneous coronary intervention, such as more accurate vessel measurement, improved stent expansion and apposition, and complication identification. This is why the use of IVUS is a class IIa recommendation in AHA and ESC guidelines. 

¿Es frecuente el uso de IVUS para guiar la ATC?

The aim of this retrospective study was to assess the use of IVUS in complex PCI and to compare mortality and the need for target vessel revascularization in patients with IVUS guided PCI vs unguided PCI. 

Complex lesions included bifurcations, chronic total occlusion, unprotected left main, long lesions >33 mm, instent restenosis, severe calcifications, multivessel PCI, and multiple stenting.  

Primary end point was mortality and target vessel revascularization at 2 years. 

In 44305 patients receiving complex lesion PCI, 13.9% of procedures were guided by IVUS: 33% of these were on left main lesions, 15% multiple stenting, 14% multivessel PCI, and 14% long lesions. The use of IVUS guided PCI grew from 13% in 2014 to 16% in 2018.

Read also: High Risk of Bleeding after PCI: More Evidence for Short DAPT.

Patients in the IVUS guided arm more often presented ejection fraction >50%, with left main and proximal descending artery compromise, and the use of drug eluting stents, while also less frequently presented recent MI, right coronary artery compromise and lesions in small and tortuous vessels. 

As regards results, IVUS guided PCI showed significantly lower mortality and less treated vessel revascularization at followup. 

Conclusion

The use of IVUS in complex lesion PCI occurs in low numbers despite the considerable evidence in support of its use. Treating these lesions with IVUS showed reduced morality and target vessel revascularization at midterm compared against PCI without IVUS guidance.  

Dr. Andrés Rodríguez
Member of the Editorial Board of SOLACI.org.

Original Title: Percutaneous Coronary Intervention With and Without Intravascular Ultrasound for Patients With Complex Lesions: Utilization, Mortality, and Target Vessel Revascularization.

Reference: Edward L. Hannan et al Circ Cardiovasc Interv. 2022;15:e011687.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...